Gesine Meyer-Rath
· Research Professor, Global Health - Boston University School of Public HealthBoston University · Global Health
Active 2003–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Gesine Meyer-Rath is a Research Professor at the Department of Global Health at Boston University School of Public Health. She is a physician and health economist working on the economics of HIV, TB, and COVID-19 in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. She holds a PhD in Health Economics from the London School of Hygiene and Tropical Medicine and an MD/PhD in Physiology from Free University Berlin. Before joining BUSPH, she worked in the Pediatrics Department of Charité University Hospital Berlin, at the World Health Organization, and at the London School of Hygiene and Tropical Medicine. She is based in Johannesburg, working at the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between Boston University and the University of the Witwatersrand.
Selected publications
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa
medRxiv · 2021-12-21 · 54 citations
preprintOpen accessAbstract A new SARS-CoV-2 variant of concern, Omicron (B.1.1.529), has been identified based on genomic sequencing and epidemiological data in South Africa. Presumptive Omicron cases in South Africa have grown extremely rapidly, despite high prior exposure and moderate vaccination coverage. The available evidence suggests that Omicron spread is at least in part due to evasion of this immune protection, though Omicron may also exhibit higher intrinsic transmissibility. Using detailed laboratory a…
Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
Open Forum Infectious Diseases · 2021-01-29 · 44 citations
articleOpen accessBACKGROUND: Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)-related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. METHODS: We projected intensive care unit (ICU) needs and capacity from August 2020 to January 2021 using the South African National COVID-19 Epi Model. We assessed the cost-effectiveness of (1) administration of dexamethasone to ventilated patients and remdesivir to n…
The Effects of Reductions in United States Foreign Assistance on Global Health
SSRN Electronic Journal · 2025-01-01 · 21 citations
preprintOpen accessAIDS · 2025-06-20 · 9 citations
articleOpen access1st authorCorrespondingBACKGROUND: Globally, shifts in United States foreign-aid policy have put HIV funding under duress. South Africa is unique in the region because its HIV program is largely domestically funded, although donor funds and partnerships support key components. We estimated the potential epidemiological impact of ceasing provision of services currently supported by PEPFAR and the costs and cost-effectiveness to the South African government (SAG) of potentially taking over these services. METHODS: We us…
BMJ Global Health · 2025-08-01 · 8 citations
articleOpen accessINTRODUCTION: Effective strategies are essential for early tuberculosis (TB) detection. Reliance on passive case detection, symptom screening and collection of sputum results in delayed or undiagnosed TB, contributing to on-going TB transmission. This study assessed the acceptability of in-home targeted universal TB testing (TUTT) using GeneXpert MTB/RIF Ultra at point-of-care (POC) during household contact investigations (HCIs) and the feasibility of using sputum and tongue swab specimens. METH…
Similar researchers at Boston University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Gesine Meyer-Rath
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup